For premenopausal patients with ER/PR+ Her2 negative breast cancer and lymph node micrometastases, would recurrence score be most appropriately interpreted based on TAILORx data, given such patients were excluded from RxPONDER?   


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Warren Alpert Medical School of Brown University
I agree but would take the volume of nodal involve...
Medical Oncologist at Ascension Michigan St. John Hospital
Would you tend to avoid it if pN1mic then? That&rs...
Sign in or Register to read more